Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionBacterial DNA gyrase inhibitor that is structurally and mechanistically distinct from fluoroquinolones
Molecular Target DNA gyrase
Mechanism of ActionProkaryotic replication inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat antibiotic-resistant bacterial infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today